Loading…

Natural cannabinoids: Templates for drug discovery

Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3 n-pentyl side chain in the most prominently represented cannabinoids from Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3 n-propyl sid...

Full description

Saved in:
Bibliographic Details
Published in:Life sciences (1973) 2005-12, Vol.78 (5), p.454-466
Main Authors: Thakur, Ganesh A., Duclos, Richard I., Makriyannis, Alexandros
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83
cites cdi_FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83
container_end_page 466
container_issue 5
container_start_page 454
container_title Life sciences (1973)
container_volume 78
creator Thakur, Ganesh A.
Duclos, Richard I.
Makriyannis, Alexandros
description Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3 n-pentyl side chain in the most prominently represented cannabinoids from Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3 n-propyl side chain containing cannabinoids are also found, although in lesser quantities. Structure–activity relationship (SAR) studies performed on Δ 9-tetrahydrocannabinol (Δ 9-THC), the key psychoactive ingredient of Cannabis, and its synthetic analogues have identified the C-3 side chain as the key pharmacophore for ligand affinity and selectivity for the known cannabinoid receptors and for pharmacological potency. Interestingly, the terminal n-pentyl saturated hydrocarbon side chain of endocannabinoids also plays a corresponding crucial role in conferring similar properties. This review briefly summarizes the biosynthesis of cannabinoids and endocannabinoids and focuses on their side chain SAR.
doi_str_mv 10.1016/j.lfs.2005.09.014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68815860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002432050500888X</els_id><sourcerecordid>68815860</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EoqXwA1hQJraEa8dxHJhQxUuqYCmz5dg3yFUexU6Q-u9x1UpsTHf5ztG5HyHXFDIKVNxtsrYJGQMoMqgyoPyEzKksqxRETk_JHIDxNGdQzMhFCBuIYFHm52RGBeOMFuWcsHc9Tl63idF9r2vXD86G-2SN3bbVI4akGXxi_fSVWBfM8IN-d0nOGt0GvDreBfl8flovX9PVx8vb8nGVGk7LMS2ELW3V1DUvEQSAtagRtWZcC850lXOh65JLqRsuuTF5ITXkjLLK1NRYmS_I7aF364fvCcOoujgB21b3OExBCSlpIQVEkB5A44cQPDZq612n_U5RUHtRaqOiKLUXpaBSUVTM3BzLp7pD-5c4monAwwHA-OKPQ6-CcdgbtM6jGZUd3D_1vyx4eI0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68815860</pqid></control><display><type>article</type><title>Natural cannabinoids: Templates for drug discovery</title><source>Elsevier</source><creator>Thakur, Ganesh A. ; Duclos, Richard I. ; Makriyannis, Alexandros</creator><creatorcontrib>Thakur, Ganesh A. ; Duclos, Richard I. ; Makriyannis, Alexandros</creatorcontrib><description>Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3 n-pentyl side chain in the most prominently represented cannabinoids from Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3 n-propyl side chain containing cannabinoids are also found, although in lesser quantities. Structure–activity relationship (SAR) studies performed on Δ 9-tetrahydrocannabinol (Δ 9-THC), the key psychoactive ingredient of Cannabis, and its synthetic analogues have identified the C-3 side chain as the key pharmacophore for ligand affinity and selectivity for the known cannabinoid receptors and for pharmacological potency. Interestingly, the terminal n-pentyl saturated hydrocarbon side chain of endocannabinoids also plays a corresponding crucial role in conferring similar properties. This review briefly summarizes the biosynthesis of cannabinoids and endocannabinoids and focuses on their side chain SAR.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2005.09.014</identifier><identifier>PMID: 16242157</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Anandamide ; Animals ; Biosynthesis ; Cannabinoid Receptor Modulators - biosynthesis ; Cannabinoid Receptor Modulators - chemistry ; Cannabinoid Receptor Modulators - pharmacology ; Cannabinoids - biosynthesis ; Cannabinoids - chemistry ; Cannabinoids - pharmacology ; Endocannabinoids ; Humans ; Molecular Conformation ; Pharmacology ; Side chain SAR ; Structure-Activity Relationship ; Δ 9-Tetrahydrocannabinol</subject><ispartof>Life sciences (1973), 2005-12, Vol.78 (5), p.454-466</ispartof><rights>2005 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83</citedby><cites>FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16242157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thakur, Ganesh A.</creatorcontrib><creatorcontrib>Duclos, Richard I.</creatorcontrib><creatorcontrib>Makriyannis, Alexandros</creatorcontrib><title>Natural cannabinoids: Templates for drug discovery</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3 n-pentyl side chain in the most prominently represented cannabinoids from Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3 n-propyl side chain containing cannabinoids are also found, although in lesser quantities. Structure–activity relationship (SAR) studies performed on Δ 9-tetrahydrocannabinol (Δ 9-THC), the key psychoactive ingredient of Cannabis, and its synthetic analogues have identified the C-3 side chain as the key pharmacophore for ligand affinity and selectivity for the known cannabinoid receptors and for pharmacological potency. Interestingly, the terminal n-pentyl saturated hydrocarbon side chain of endocannabinoids also plays a corresponding crucial role in conferring similar properties. This review briefly summarizes the biosynthesis of cannabinoids and endocannabinoids and focuses on their side chain SAR.</description><subject>Anandamide</subject><subject>Animals</subject><subject>Biosynthesis</subject><subject>Cannabinoid Receptor Modulators - biosynthesis</subject><subject>Cannabinoid Receptor Modulators - chemistry</subject><subject>Cannabinoid Receptor Modulators - pharmacology</subject><subject>Cannabinoids - biosynthesis</subject><subject>Cannabinoids - chemistry</subject><subject>Cannabinoids - pharmacology</subject><subject>Endocannabinoids</subject><subject>Humans</subject><subject>Molecular Conformation</subject><subject>Pharmacology</subject><subject>Side chain SAR</subject><subject>Structure-Activity Relationship</subject><subject>Δ 9-Tetrahydrocannabinol</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kDtPwzAUhS0EoqXwA1hQJraEa8dxHJhQxUuqYCmz5dg3yFUexU6Q-u9x1UpsTHf5ztG5HyHXFDIKVNxtsrYJGQMoMqgyoPyEzKksqxRETk_JHIDxNGdQzMhFCBuIYFHm52RGBeOMFuWcsHc9Tl63idF9r2vXD86G-2SN3bbVI4akGXxi_fSVWBfM8IN-d0nOGt0GvDreBfl8flovX9PVx8vb8nGVGk7LMS2ELW3V1DUvEQSAtagRtWZcC850lXOh65JLqRsuuTF5ITXkjLLK1NRYmS_I7aF364fvCcOoujgB21b3OExBCSlpIQVEkB5A44cQPDZq612n_U5RUHtRaqOiKLUXpaBSUVTM3BzLp7pD-5c4monAwwHA-OKPQ6-CcdgbtM6jGZUd3D_1vyx4eI0</recordid><startdate>20051222</startdate><enddate>20051222</enddate><creator>Thakur, Ganesh A.</creator><creator>Duclos, Richard I.</creator><creator>Makriyannis, Alexandros</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051222</creationdate><title>Natural cannabinoids: Templates for drug discovery</title><author>Thakur, Ganesh A. ; Duclos, Richard I. ; Makriyannis, Alexandros</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anandamide</topic><topic>Animals</topic><topic>Biosynthesis</topic><topic>Cannabinoid Receptor Modulators - biosynthesis</topic><topic>Cannabinoid Receptor Modulators - chemistry</topic><topic>Cannabinoid Receptor Modulators - pharmacology</topic><topic>Cannabinoids - biosynthesis</topic><topic>Cannabinoids - chemistry</topic><topic>Cannabinoids - pharmacology</topic><topic>Endocannabinoids</topic><topic>Humans</topic><topic>Molecular Conformation</topic><topic>Pharmacology</topic><topic>Side chain SAR</topic><topic>Structure-Activity Relationship</topic><topic>Δ 9-Tetrahydrocannabinol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thakur, Ganesh A.</creatorcontrib><creatorcontrib>Duclos, Richard I.</creatorcontrib><creatorcontrib>Makriyannis, Alexandros</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thakur, Ganesh A.</au><au>Duclos, Richard I.</au><au>Makriyannis, Alexandros</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natural cannabinoids: Templates for drug discovery</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2005-12-22</date><risdate>2005</risdate><volume>78</volume><issue>5</issue><spage>454</spage><epage>466</epage><pages>454-466</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3 n-pentyl side chain in the most prominently represented cannabinoids from Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3 n-propyl side chain containing cannabinoids are also found, although in lesser quantities. Structure–activity relationship (SAR) studies performed on Δ 9-tetrahydrocannabinol (Δ 9-THC), the key psychoactive ingredient of Cannabis, and its synthetic analogues have identified the C-3 side chain as the key pharmacophore for ligand affinity and selectivity for the known cannabinoid receptors and for pharmacological potency. Interestingly, the terminal n-pentyl saturated hydrocarbon side chain of endocannabinoids also plays a corresponding crucial role in conferring similar properties. This review briefly summarizes the biosynthesis of cannabinoids and endocannabinoids and focuses on their side chain SAR.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>16242157</pmid><doi>10.1016/j.lfs.2005.09.014</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2005-12, Vol.78 (5), p.454-466
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_68815860
source Elsevier
subjects Anandamide
Animals
Biosynthesis
Cannabinoid Receptor Modulators - biosynthesis
Cannabinoid Receptor Modulators - chemistry
Cannabinoid Receptor Modulators - pharmacology
Cannabinoids - biosynthesis
Cannabinoids - chemistry
Cannabinoids - pharmacology
Endocannabinoids
Humans
Molecular Conformation
Pharmacology
Side chain SAR
Structure-Activity Relationship
Δ 9-Tetrahydrocannabinol
title Natural cannabinoids: Templates for drug discovery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A23%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natural%20cannabinoids:%20Templates%20for%20drug%20discovery&rft.jtitle=Life%20sciences%20(1973)&rft.au=Thakur,%20Ganesh%20A.&rft.date=2005-12-22&rft.volume=78&rft.issue=5&rft.spage=454&rft.epage=466&rft.pages=454-466&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2005.09.014&rft_dat=%3Cproquest_cross%3E68815860%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-56d7d9fbb47e0600ddeaeeaa24a642a9346ab7488af484cc358a032129cb1cd83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68815860&rft_id=info:pmid/16242157&rfr_iscdi=true